CClinicalTrials.gg
Sign In
Status unknownNCT00984191Updated Jun 27, 2011

Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

An interventional study of 99mTc-MIBI SPECT-CT in Papillary Thyroid Cancer, sponsored by Chulalongkorn University. Status unknown at 1 site in Thailand. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-06-27.

Sponsored by Chulalongkorn University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Jun 2011), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this trial is to see if the 99mTechnetium-MIBI SPECT-CT can be a tool for preoperative evaluation of cervical node metastasis in papillary thyroid cancer.

02

Conditions studied

  • Papillary Thyroid Cancer

Keywords

  • Papillary thyroid cancer
  • 99mTechnetium MIBI SPECT CT
  • preoperative
  • cervical lymphadenopathy
  • cervical metastasis
03

In context

Thyroid Neoplasms

802 studies on the registry are indexed under Thyroid Neoplasms; 216 are open to participants now.

This study's planned enrollment of 15 is below the median of 51 across 507 interventional studies indexed under Thyroid Neoplasms.

Browse Thyroid Neoplasms studies →

Lead sponsor

Chulalongkorn University is the lead sponsor of 312 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • papillary thyroid cancer

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • Bleeding abnormality
  • Prior history of head and neck cancer
  • can not perform 99mTechnetium-MIBI SPECT-CT
  • can not perform 131I remnant Ablation
  • Prior any head and neck surgery within 3 months
  • Prior deep neck infection within 3 months
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    99mTc positive

    99mTechnetium-MIBI SPECT-CT positive compare : Scan - Pathologic report

    Radiation: 99mTc-MIBI SPECT-CT

  • Experimental
    99mTc Negative_Neck dissection

    99mTc Negative but have neck dissection indication compare : 99mTc - Pathologic report

    Radiation: 99mTc-MIBI SPECT-CT

  • Experimental
    99mTc Negative_No neck dissection

    99mTc Negative and No other indication for neck dissection compare : 99mTc - 7. 131I (post-treatment) whole body scan

    Radiation: 99mTc-MIBI SPECT-CT

Interventions

  • Radiation99mTc-MIBI SPECT-CT

    99mTc-MIBI SPECT-CT for abnormal cervical lymph node

06

What researchers measure

Primary outcomes

  1. Diagnostic Tool Statistic (PPV , NPV , Sensitivity , Specificity , Accuracy )

    Time frame: 18 months

07

Study locations

1 site
  • King Chulalongkorn Hospital
    Pathumwan, Bangkok 10330, Thailand
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00984191
Lead sponsor
Chulalongkorn University
First posted
Sep 25, 2009
Start date
Mar 2010
Primary completion
Oct 2011 (estimated)
Completion
Nov 2011 (estimated)
Last update
Jun 27, 2011

Study contacts

Napadon Tangjaturonrasme, Otolaryngologist
principal investigator · Department of Otolaryngology , Faculty of Medicine , Chulalongkorn University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Thyroid Neoplasms→

Other studies from this sponsor

Chulalongkorn University

Start the discussion